RXR Agonists Enhance Lenalidomide Anti-Myeloma Activity and T Cell Functions While Retaining Glucose-Lowering Effect.
Cells（2023）
Key words
immunomodulatory drugs,PPAR,diabetes,dyslipidemia,CpG island,methylation,metabolomics,treatment response,survival
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined